At least 600 CDC employees getting final termination notices, union says
New York, Aug 20 (AP) At least 600 employees of the Centres for Disease Control and Prevention are receiving permanent termination notices in the wake of a recent court decision that protected some CDC employees from layoffs but not others.
The notices went out this week and many people have not yet received them, according to the American Federation of Government Employees, which represents more than 2,000 dues-paying members at CDC.
The US Department of Health and Human Services on Wednesday did not offer details on the layoffs and referred an AP reporter to a March statement that said restructuring and downsizing were intended to make health agencies more responsive and efficient.
AFGE officials said they are aware of at least 600 CDC employees being cut.
But 'due to a staggering lack of transparency from HHS," the union hasn't received formal notices of who is being laid off," the federation said in a statement on Wednesday.
The permanent cuts include about 100 people who worked in violence prevention. Some employees noted those cuts come less than two weeks after a man fired at least 180 bullets into the CDC's campus and killed a police officer.
'The irony is devastating: The very experts trained to understand, interrupt and prevent this kind of violence were among those whose jobs were eliminated," some of the affected employees wrote in a blog post last week.
On April 1, the HHS officials sent layoff notices to thousands of employees at the CDC and other federal health agencies, part of a sweeping overhaul designed to vastly shrink the agencies responsible for protecting and promoting Americans' health.
Many have been on administrative leave since then — paid but not allowed to work — as lawsuits played out.
A federal judge in Rhode Island last week issued a preliminary ruling that protected employees in several parts of the CDC, including groups dealing with smoking, reproductive health, environmental health, workplace safety, birth defects and sexually transmitted diseases.
But the ruling did not protect other CDC employees, and layoffs are being finalised across other parts of the agency, including in the freedom of information office. The terminations were effective as of Monday, employees were told.
Affected projects included work to prevent rape, child abuse and teen dating violence. The laid-off staff included people who have helped other countries to track violence against children — an effort that helped give rise to an international conference in November at which countries talked about setting violence-reduction goals.
'There are nationally and internationally recognised experts that will be impossible to replace," said Tom Simon, the retired senior director for scientific programmes at the CDC's Division of Violence Prevention. (AP) SCY SCY
view comments
First Published:
August 21, 2025, 03:30 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Loading comments...
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Can matcha mess with the body's iron levels? Here's what experts say
Image credits: Getty Images Matcha might not match-a with the body! If you've jumped on the matcha train, just like the rest of the world on the internet, then it might be time to step down and evaluate. Nutritionists are warning that the trending drink could be hampering the body's iron levels, raising your risk of anaemia and leaving you feeling weak and worn out. What is matcha? Image credits: Getty Images Matcha, originating from Japan is a beverage made from specially grown and processed green tea leaves, which are ground into a fine powder and whisked with hot water. The bright green drink that has been a staple in Japan for years, has now not only taken over social media feeds but also people's kitchens, rising as an alternative to the evergreen black tea and coffee. Why is matcha matching new tastes? Image credits: Getty Images Matcha contains an amino acid called I-theanine, known for its calming effects. 'This, in combination with matcha's natural caffeine content, provides a nice boost of energy, all without all the anxiety and jitters that come with coffee,' said Sarah Martel, a registered dietitian, to the Toronto Star. Additionally, the much-loved beverage is also rich in antioxidants like catechins that may help fight cell damage, reduce inflammation and lower the risk of chronic diseases, including cancer. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Your Finger Shape Says a Lot About Your Personality, Read Now Tips and Tricks Undo Matcha and iron levels Image credits: Getty Images However, lately, various users on social media have been waving flags about the drink's potential to affect the body's ability to absorb iron. Iron is a key component in haemoglobin, the protein in red blood cells that transfers oxygen from the lungs to the entire body and is also vital for brain development, hormone production and overall cell function. Matcha contains tannins that bond to non-heme iron, a form of iron found in plants and can in turn block the body's ability to absorb iron, Farzanah Nasser, a nutritionist told Vogue. If left unchecked, this can cause iron deficiency, which affects about 10 million Americans and can also progress into iron deficiency anaemia, which impacts about 5 million Americans. As the iron levels drop, symptoms such as extreme fatigue, pale skin, shortness of breath, headaches, dizziness, brittle nails and strange cravings for ice, dirt or starch can develop and persist. 'Drinking matcha with or immediately after meals will have a stronger inhibitory effect on iron absorption than drinking it between meals,' said Kirbie Daily, assistant director of Olympic Nutrition at the University of Memphis, to Thus, if you have matcha with a 1-2 hour gap between your meals and iron supplementation, then matcha can still match-a with your routine.
Hindustan Times
2 hours ago
- Hindustan Times
RFK Jr's attack on mRNA technology endangers the world
DURING THE covid-19 pandemic new vaccines were rolled out with unprecedented speed. The fastest to arrive were jabs built from molecules of messenger RNA (mRNA) designed to teach the body how to fight off the disease-causing virus. By late 2021, mRNA vaccines had saved an estimated 7.7m lives globally, including most of the 3m Americans whom the Commonwealth Fund, an American health-care charity, estimates were saved by vaccines before 2023. President Donald Trump was one of the technology's many supporters. He launched Operation Warp Speed, a programme that started the race to deliver vaccines. He even received an mRNA shot and advocated (albeit gently) for their use. Yet today many Americans are suspicious of these jabs. The speed with which they were developed and approved, coupled with sweeping vaccine mandates and a political push by the Biden administration to give booster shots ahead of any decision being made by scientists at the drug regulator, caused anger and mistrust. Rampant disinformation has further stirred the pot, leading many to wrongly believe that mRNA vaccines have killed or harmed millions of people. Chart Robert F. Kennedy junior, Mr Trump's health secretary, is known for his opposition to vaccines in general and mRNA in particular. Earlier this month, citing safety concerns that scientists have discredited, his department terminated 22 mRNA-related contracts worth a total of nearly $500m across academia and industry. America, said Mr Kennedy, was moving beyond the 'limitations of mRNA and investing in better solutions'. The move is not an isolated one. In May Mr Kennedy's department cancelled $766m in funding for a late-stage human mRNA vaccine against bird flu and work on five subtypes of flu with pandemic potential. America also gave up the rights to purchase bird-flu shots from Moderna, a company with which it had previously collaborated to deliver these vaccines. Rick Bright, the former boss of the Biomedical Advanced Research and Development Authority—the division of the health department that had funded the grants—wrote in the New York Times that the latest decision undercut 'one of the most significant medical advances in decades…that could protect millions more people from the threats ahead'. This is no understatement. In the years since the pandemic, mRNA has emerged as a powerful new 'platform' technology; one that can be used not only to design new pandemic-busting vaccines, but also to create medicines for infectious diseases, rare genetic diseases and cancer. The rapidity with which mRNA can be designed and manufactured makes it ideally suited for creating a new generation of personalised medicines. The cuts risk making the world a more dangerous place. To assess the impact of the cuts, The Economist spoke to more than half a dozen experts. Most declined to be quoted on the record. 'Everyone is trying to do everything we can to avoid the glare of RFK,' said one source at a research-funding institution. He explained that his organisation was removing references to RNA wherever possible and trying to work out alternative ways of describing it. This is an infuriating task, he says. 'It is a bit you can't use the word carbon.' mRNA is similarly fundamental to biology. It is the specific type of RNA that acts as a messenger carrying instructions from a cell's DNA to protein-production units known as ribosomes. The ability to harness mRNA—as well as related molecules in the cell—has given medicine an enormously powerful tool. Scientists can now instruct the body to manufacture therapeutic proteins; train the immune system to fight diseases, including cancers; and even silence harmful signals in cells, such as faulty instructions caused by a genetic disease or genetic information from a virus seeking to use the cell's machinery to replicate itself. Mr Kennedy has implied his department's cuts are limited to mRNA vaccines for respiratory infections. But this does not appear to be the case. Biospace, an online publication, reports that research into filoviruses such as Ebola—which are not respiratory but cause haemorrhagic fevers through direct contact with bodily fluids—has also lost funding. Other cuts target treatments rather than vaccines. One such casualty is ModeX, a biotech firm based in Massachusetts, which is developing therapeutic antibodies. An antibody infusion—which is distinct from a vaccine—can be lifesaving for patients struggling to fight off a virus. ModeX is engineering mRNA that, when introduced into the body, instructs it to create antibodies able to attach to more than one location on a given virus, which should make them more potent. Some affected research appears to have nothing to do with mRNA at all. Fierce Biotech, another online outlet, noted that Tiba Biotech in Cambridge, Massachusetts, had been developing a flu treatment based on RNA interference (RNAi)—a different technology altogether—when it lost funding. It sought to create a tiny RNA molecule that would interfere with the production of viral proteins in the body, potentially blocking the virus from replicating. But perhaps the most significant impact of the cuts will be on the world's ability to produce vaccines against a future pandemic. America is the global leader in mRNA-vaccine research; according to Airfinity, a life-sciences data firm, it is currently home to trials for almost 40% of mRNA vaccine candidates (see chart). In the years prior to the pandemic the government spent $337m funding research related to mRNA technology that would lead to the covid-19 vaccines, a figure unmatched by any other country. Some hope that investors will work around the government's disdain for respiratory mRNA vaccines and continue to invest in RNA therapeutics more broadly. But there are already signs of trouble: one industry source says that the administration's hostility—particularly in the form of inaccurate comments made about the safety of mRNA vaccines—is already having a chilling effect. The cost of manufacturing mRNA will probably rise and young talent and seasoned experts could leave the field, hampering innovation in an area of biology rich in applications. This may in particular hurt the development of personalised cancer vaccines, a promising mRNA-based technology to treat tumours. OncoDaily, an online publication, suggests that the funding cuts could increase per-patient manufacturing costs by 20-40% and extend production timelines by two to six weeks. Slower speeds of delivery can give a tumour time to spread and may, therefore, reduce the efficacy of a vaccine. Trials may also be forced to slow down or move abroad. There are few precedents for such a sequence of events. When George W. Bush's administration restricted funding for embryonic stem-cell research in 2001, some scientists did eventually move abroad. Britain benefited; it became a global hub for research on embryonic stem cells. The cuts also pushed American researchers to innovate in other areas, leading to the advancement of pluripotent stem cells. The current administration hopes to repeat the trick by advancing conventional whole-vaccine platforms to tackle pandemics. But it seems unlikely that these could ever be developed as quickly as mRNA jabs, which some experts reckon could be turned around in 100 days. As for where mRNA expertise may go, there are whispers of interest from Saudi Arabia, Switzerland and the United Arab Emirates. Britain is actively competing for it, says one British source. Peter Piot, a professor of global health at the London School of Hygiene and Tropical Medicine and, until recently, an adviser to Ursula von der Leyen, president of the European Commission, thinks that the European Union should launch a special initiative to pick up the ball that America has dropped. One can only hope that his call is heeded before the next pandemic arrives.
Time of India
6 hours ago
- Time of India
US health officials urge Kennedy to stop spreading vaccine misinformation
Washington: Hundreds of current and former employees of US health agencies on Wednesday accused President Donald Trump's health secretary of putting them at risk by spreading false information. In an open letter, the federal officials criticized Secretary Robert F. Kennedy Jr. -- a noted vaccine skeptic -- nearly two weeks after an armed attack on the headquarters of the Centers for Disease Control and Prevention (CDC), the main US health agency. A gunman who blamed the Covid-19 vaccine for sickening him targeted several buildings at the Atlanta-based CDC on August 8, killing a police officer. The attack "was not random," the signees of the open letter said, pointing to "growing mistrust in public institutions, driven by politicized rhetoric that has turned public health professionals from trusted experts into targets of villainization -- and now, violence." Kennedy, who has repeatedly aired false information about vaccines and slammed the agencies he heads as corrupt, was accused of fueling the mistrust. Kennedy "is complicit in dismantling America's public health infrastructure and endangering the nation's health by repeatedly spreading inaccurate health information," the open letter said, imploring the health chief to change his stance. Since taking office, the nephew of assassinated president John F. Kennedy has made numerous pronouncements that run counter to scientific consensus, particularly about vaccines. This shift toward vaccine skepticism has been denounced by many experts. A petition calling on Congress to impeach Kennedy had gathered more than 12,600 signatures as of Wednesday. The latest open letter from US civil servants, many of whom signed anonymously, comes on the heels of other similar texts backed by federal employees denouncing actions of the Trump administration. Taking such a step was not without risk: nearly 140 staffers at the Environmental Protection Agency who spoke out publicly were placed on leave in last month.
